RxDoctor Payments Data

Angela Law, MD

Family Medicine · Omaha, NENPI 1336294487

Payments from drug & device makers

$1,057in general payments, 2019–2025

Across 59 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$139
  • AbbVie$104
  • Novo Nordisk$96
  • Amgen$87
  • AstraZeneca$79
  • Pfizer$65
  • plus $488 from 16 others

What the payments were for

  • Food & beverage$1,057100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,057 in reported general payments places this provider in the 60th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$132,598
Medicare patients
192
Services billed
3,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide32$32,453
EliquisApixaban27$22,937
JardianceEmpagliflozin16$21,244
TrulicityDulaglutide14$14,300
OzempicSemaglutide11$14,030
SymbicortBudesonide/Formoterol Fumarate12$5,723
Atorvastatin Calcium345$2,286
LantusInsulin Glargine,hum.Rec.Anlog12$2,165
Varenicline Tartrate11$2,101
Metoprolol Succinate92$1,463
SynthroidLevothyroxine Sodium23$1,338
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,189
Bupropion XlBupropion Hcl34$1,127
Levothyroxine Sodium159$1,083
Losartan Potassium130$1,078

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$139$46,75346 claims
PfizerEliquis$65$22,93727 claims
Novo NordiskOzempic$96$14,03011 claims
AstraZenecaSymbicort$79$5,72312 claims
AbbVieSynthroid$104$1,33823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 981 family medicine providers in Nebraska.

Other family medicine in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →